Maze Therapeutics Statistics
Total Valuation
MAZE has a market cap or net worth of $1.63 billion. The enterprise value is $1.20 billion.
| Market Cap | 1.63B |
| Enterprise Value | 1.20B |
Important Dates
The last earnings date was Tuesday, August 11, 2026, after market close.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MAZE has 55.55 million shares outstanding. The number of shares has increased by 174.46% in one year.
| Current Share Class | 55.55M |
| Shares Outstanding | 55.55M |
| Shares Change (YoY) | +174.46% |
| Shares Change (QoQ) | +9.46% |
| Owned by Insiders (%) | 0.85% |
| Owned by Institutions (%) | 73.84% |
| Float | 36.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 81.74 |
| Forward PS | 281.86 |
| PB Ratio | 3.60 |
| P/TBV Ratio | 3.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 60.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.31, with a Debt / Equity ratio of 0.13.
| Current Ratio | 18.31 |
| Quick Ratio | 18.03 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -81.03 |
Financial Efficiency
Return on equity (ROE) is -37.35% and return on invested capital (ROIC) is -190.34%.
| Return on Equity (ROE) | -37.35% |
| Return on Assets (ROA) | -21.79% |
| Return on Invested Capital (ROIC) | -190.34% |
| Return on Capital Employed (ROCE) | -28.63% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $141,844 |
| Profits Per Employee | -$947,447 |
| Employee Count | 141 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +118.32% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +118.32% |
| 50-Day Moving Average | 28.13 |
| 200-Day Moving Average | 34.40 |
| Relative Strength Index (RSI) | 57.15 |
| Average Volume (20 Days) | 362,257 |
Short Selling Information
The latest short interest is 5.68 million, so 10.22% of the outstanding shares have been sold short.
| Short Interest | 5.68M |
| Short Previous Month | 5.53M |
| Short % of Shares Out | 10.22% |
| Short % of Float | 15.44% |
| Short Ratio (days to cover) | 11.24 |
Income Statement
In the last 12 months, MAZE had revenue of $20.00 million and -$133.59 million in losses. Loss per share was -$2.52.
| Revenue | 20.00M |
| Gross Profit | 20.00M |
| Operating Income | -145.61M |
| Pretax Income | -133.59M |
| Net Income | -133.59M |
| EBITDA | -143.71M |
| EBIT | -145.61M |
| Loss Per Share | -$2.52 |
Balance Sheet
The company has $411.09 million in cash and $60.42 million in debt, with a net cash position of $434.49 million or $7.82 per share.
| Cash & Cash Equivalents | 411.09M |
| Total Debt | 60.42M |
| Net Cash | 434.49M |
| Net Cash Per Share | $7.82 |
| Equity (Book Value) | 453.12M |
| Book Value Per Share | 8.16 |
| Working Capital | 397.46M |
Cash Flow
In the last 12 months, operating cash flow was -$106.54 million and capital expenditures -$302,000, giving a free cash flow of -$106.84 million.
| Operating Cash Flow | -106.54M |
| Capital Expenditures | -302,000 |
| Depreciation & Amortization | 1.91M |
| Net Borrowing | 39.40M |
| Free Cash Flow | -106.84M |
| FCF Per Share | -$1.92 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -728.06% |
| Pretax Margin | -667.95% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MAZE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -174.46% |
| Shareholder Yield | -174.46% |
| Earnings Yield | -8.17% |
| FCF Yield | -6.54% |
Analyst Forecast
The average price target for MAZE is $62.55, which is 112.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $62.55 |
| Price Target Difference | 112.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MAZE has an Altman Z-Score of 9.75 and a Piotroski F-Score of 3.
| Altman Z-Score | 9.75 |
| Piotroski F-Score | 3 |